Effect of Andiroba on Control of Post-whitening Tooth Sensitivity
Launched by UNIVERSIDADE FEDERAL DO PARA · Sep 24, 2024
Trial Information
Current as of July 31, 2025
Completed
Keywords
ClinConnect Summary
All groups will undergo in-office whitening treatment, carried out in 3 sessions with a 7-day interval, according to the steps described below:
Prophylaxis; Application of gingival barrier; Application of desensitizing agent or placebo, according to the established groups; Handling of the whitening material following the manufacturer's instructions: application of Whiteness HP 35% whitening gel for 15 minutes each, totaling 45 minutes; Final removal of the whitening gel and gingival barrier, followed by rinsing with water.
The application of the desensitizing agent or its placebo will fol...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • good oral hygiene
- • absence of active caries lesions
- • never having undergone previous whitening therapy
- • not present dental hypersensitivity
- • don\'t be a smoker
- • not be pregnant
- • present at least 28 teeth in the oral cavity.
- Exclusion Criteria:
- • volunteers who were under orthodontic treatment,
- • presence of periodontal disease
- • dental cracks or fractures
- • restorations and prostheses on anterior teeth
- • extensive molar restorations
- • gastroesophageal disorders
- • severe internal dental darkening
- • presence of dentinal exposure in anterior and / or posterior teeth.
About Universidade Federal Do Para
The Universidade Federal do Pará (UFPA) is a prominent Brazilian institution dedicated to advancing research and education in various fields, including health sciences. As a clinical trial sponsor, UFPA leverages its extensive academic resources and expertise to design, implement, and oversee innovative research studies aimed at improving health outcomes and contributing to the scientific community. The university fosters collaboration among researchers, healthcare professionals, and stakeholders to ensure rigorous methodologies and ethical standards are upheld throughout the research process, ultimately striving to translate findings into practical applications that benefit public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Belém, Pará, Brazil
Belém, , Brazil
Patients applied
Trial Officials
Cecy M Silva, doctor
Principal Investigator
Universidade federal do Pará
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported